Reset Therapeutics

About:

Reset Therapeutics, a biopharmaceutical company, develops and commercializes products that modulate the circadian system of the human body.

Website: http://resettherapeutics.com

Twitter/X: resettx

Description:

Reset Therapeutics is a biopharmaceutical company formed to discover, develop and commercialize new therapeutics that modulate the circadian system, the body’s network of internal molecular clocks.

Total Funding Amount:

$53.6M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

South San Francisco, California, United States

Founded Date:

2008-01-01

Contact Email:

info(AT)resettherapeutics.com

Founders:

Ross Bersot

Number of Employees:

11-50

Last Funding Date:

2016-02-19

IPO Status:

Private

Industries:

© 2025 bioDAO.ai